Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Motor Activity 19 Polycystic Ovary Syndrome 10 Prostatic Neoplasms 7 Breast Neoplasms 6 Neoplasms 5 Colorectal Neoplasms 4 Insulin Resistance 3 Lung Neoplasms 2 Fatigue 2 Esophageal Neoplasms 2 Cardiotoxicity 2 Stomach Neoplasms 1 Rectal Neoplasms 1 Primary Dysautonomias 1 Pediatric Brain Tumor 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Lymphoma, Follicular 1 Lupus Erythematosus, Systemic 1 Inflammation 1 Hodgkin Disease 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Disease 1 Diabetes Mellitus, Type 1 1 Chemotherapy-Related Cognitive Impairment 1 Cardiovascular Diseases 1 Carcinoma, Hepatocellular 1 Cachexia 1

Interventions

Exercise 5 Standard of Care 3 Blood Specimen Collection 3 Resistance Training 2 Diet Therapy 2 fucoidan 1 dermcidin 1 Vitamin D 1 Physical Therapy Modalities 1 Palliative Care 1 Nutritional Support 1 Nutrition Assessment 1 Nandrolone Decanoate 1 Melatonin 1 MME 1 Ibuprofen 1 High-Intensity Interval Training 1 High-Energy Shock Waves 1 Fundoplication 1 Food 1 Flour 1 Enteral Nutrition 1 Dietary Supplements 1 Dexamethasone 1 Curcumin 1 Control Groups 1 Combined Modality Therapy 1 Cholecystectomy 1 Cholecalciferol 1 Celecoxib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Cachexia × High-Intensity Interval Training × Clear all

NCT04065815 2019-08-22

PROTECT

University of Erlangen-Nürnberg Medical School

Phase NA Unknown

Cachexia, Inflammation, Motor Activity, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡